vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
15.33
+1.30 (9.27%)
Aug 14, 2025, 11:16 AM - Market open
vTv Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 25.92 | 36.75 | 9.45 | 12.13 | 13.42 | 5.75 | Upgrade
|
| Short-Term Investments | - | 0.09 | 0.07 | 0.02 | 0.1 | 0.37 | Upgrade
|
| Cash & Short-Term Investments | 25.92 | 36.83 | 9.51 | 12.14 | 13.52 | 6.12 | Upgrade
|
| Cash Growth | -43.14% | 287.25% | -21.66% | -10.17% | 120.91% | 201.83% | Upgrade
|
| Accounts Receivable | - | 0.06 | 0.1 | 0.17 | 0.06 | 0.16 | Upgrade
|
| Other Receivables | - | - | - | - | 0.14 | - | Upgrade
|
| Receivables | - | 0.06 | 0.1 | 12.42 | 0.19 | 0.16 | Upgrade
|
| Prepaid Expenses | 0.36 | 1.22 | 1.04 | 2.54 | 1.91 | 0.94 | Upgrade
|
| Total Current Assets | 26.37 | 38.11 | 10.66 | 27.09 | 15.62 | 7.22 | Upgrade
|
| Property, Plant & Equipment | 0.07 | 0.15 | 0.36 | 0.56 | 0.68 | 0.85 | Upgrade
|
| Long-Term Investments | - | - | - | 5.59 | 9.17 | 6.73 | Upgrade
|
| Total Assets | 26.45 | 38.27 | 11.02 | 33.24 | 25.47 | 14.79 | Upgrade
|
| Accounts Payable | 5.22 | 0.94 | 4.08 | 2.46 | 1.88 | 1.93 | Upgrade
|
| Accrued Expenses | - | 4.09 | 6.17 | 4.85 | 6.15 | 4.2 | Upgrade
|
| Short-Term Debt | - | - | 0.19 | 0.22 | 0.26 | 0.08 | Upgrade
|
| Current Portion of Leases | 0.08 | 0.17 | 0.17 | 0.15 | 0.18 | 0.16 | Upgrade
|
| Current Unearned Revenue | - | - | 0.02 | 0.02 | 0.04 | 0.03 | Upgrade
|
| Total Current Liabilities | 5.3 | 5.2 | 10.62 | 7.71 | 8.5 | 6.39 | Upgrade
|
| Long-Term Leases | - | - | 0.17 | 0.34 | 0.49 | 0.68 | Upgrade
|
| Long-Term Unearned Revenue | 18.67 | 18.67 | 18.67 | 18.67 | - | 1.01 | Upgrade
|
| Other Long-Term Liabilities | 0.08 | 0.1 | 0.11 | 0.68 | 1.26 | 2.92 | Upgrade
|
| Total Liabilities | 24.04 | 23.97 | 29.57 | 27.4 | 10.25 | 11 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.9 | 0.77 | Upgrade
|
| Additional Paid-In Capital | 313.59 | 311.89 | 256.34 | 254.76 | 238.19 | 209.16 | Upgrade
|
| Retained Earnings | -310.86 | -299.72 | -281.04 | -265.52 | -248.83 | -290.04 | Upgrade
|
| Total Common Equity | 2.76 | 12.2 | -24.68 | -10.74 | -9.74 | -80.1 | Upgrade
|
| Minority Interest | -0.36 | 2.1 | 6.13 | 16.58 | 24.96 | 83.9 | Upgrade
|
| Shareholders' Equity | 2.41 | 14.3 | -18.55 | 5.84 | 15.22 | 3.79 | Upgrade
|
| Total Liabilities & Equity | 26.45 | 38.27 | 11.02 | 33.24 | 25.47 | 14.79 | Upgrade
|
| Total Debt | 0.08 | 0.17 | 0.53 | 0.72 | 0.93 | 0.92 | Upgrade
|
| Net Cash (Debt) | 25.84 | 36.66 | 8.98 | 11.43 | 12.58 | 5.2 | Upgrade
|
| Net Cash Growth | -42.99% | 308.17% | -21.38% | -9.20% | 141.84% | - | Upgrade
|
| Net Cash Per Share | 9.87 | 6.35 | 4.31 | 5.95 | 8.03 | 4.42 | Upgrade
|
| Filing Date Shares Outstanding | 2.62 | 6.58 | 2.43 | 2.04 | 1.67 | 1.44 | Upgrade
|
| Total Common Shares Outstanding | 2.62 | 6.58 | 2.08 | 2.04 | 1.67 | 1.35 | Upgrade
|
| Working Capital | 21.08 | 32.92 | 0.04 | 19.39 | 7.12 | 0.83 | Upgrade
|
| Book Value Per Share | 1.06 | 1.85 | -11.84 | -5.27 | -5.82 | -59.28 | Upgrade
|
| Tangible Book Value | 2.76 | 12.2 | -24.68 | -10.74 | -9.74 | -80.1 | Upgrade
|
| Tangible Book Value Per Share | 1.06 | 1.85 | -11.84 | -5.27 | -5.82 | -59.28 | Upgrade
|
| Machinery | - | 0.12 | 0.12 | 0.12 | 0.1 | 0.1 | Upgrade
|
| Leasehold Improvements | - | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | Upgrade
|
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.